相关实验视频

Updated: Jun 13, 2025

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

基于强化学习的空间探索:加速产生类似药物的

Qian Wang¹, Xiaotong Hu¹, Zhiqiang Wei¹

¹College of Computer Science and Technology, Ocean University of China, 238 Songling Rd, 266100 Shandong, China.

Briefings in bioinformatics

|September 10, 2024

概括

这项研究引入了一种新的强化学习模型,用于生成类似药物的. 该模型使用图形注意力机制来优化序列,在满足药物特性和生物活性方面取得了90%以上的成功.

科学领域:

计算化学是一种计算化学.
药物发现药物发现
生物信息学是一种生物信息学.

背景情况:

酸生成在序列控制,定制和合成方面面临挑战.
传统的药物发现是昂贵和低效的.
以前的方法忽视了氨基酸连接性,限制了类药物增强.

研究的目的:

开发一个计算机辅助的基生成模型.
为了增强类药物的生物活性和药物相似性.
为了加速药物发现过程.

主要方法:

提出了一种基于强化学习 (RL) 的生成模型.
利用图表注意力机制来捕捉氨基酸残留的连接性.
实施了一个关键演员框架,有针对优化的反循环.

主要成果:

该模型有效地捕获了的结构信息.
产生的类似药物在满足ADMET和生物活性标准方面表现出高的成功率 (>90%).
实现了针对特定目标的定制生成,并增强了亲和力.

结论:

这种RL驱动的图表注意力模型显著加快了类似药物的生成.
这种方法为设计优化疗法提供了一种新的策略.
该模型成功地平衡了针对特定应用的多个属性.

关键词:

氨基酸残留物氨基酸残留物与药物类似的基生成.图表的注意力机制.强化学习是一种强化学习.

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly

Synthesis of Information-bearing Peptoids and their Sequence-directed Dynamic Covalent Self-assembly

Published on: February 6, 2020

相关概念视频

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...